期刊文献+

未破裂的异位妊娠临床治疗后输卵管显影情况

Tubal patency after clinical treatment of unruptured ectopic pregnancy
下载PDF
导出
摘要 Objective: To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. Method: Of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 toFebruary 2002, 30 were treated with a single 50 mg/m2 dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. Results: Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. Conclusion: Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management. Objective: To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. Method: Of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 toFebruary 2002, 30 were treated with a single 50 mg/m2 dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. Results: Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. Conclusion: Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management.
出处 《世界核心医学期刊文摘(妇产科学分册)》 2005年第7期53-53,共1页 Core Journal in Obstetrics/Gynecology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部